Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.60    1.05 (16.03%)
Bid:
7.20
Ask:
8.00
Spread: 0.80 (11.111%)
Market Cap: £9.08m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Disposal

21 Jul 2009 07:00

RNS Number : 9867V
St Helen's Capital PLC
21 July 2009
 

PRIVATE & CONFIDENTIAL

St Helen's Capital Plc

("St Helen's Capital" or the "Company")

 

Proposed Disposal of Business and Directorate Change

 

St Helen's Capital announces that on 20 July 2009 it signed heads of agreement relating to the proposed sale, subject to contract, of its business and associated assets (the "Disposal")  to Whim Gully Capital LLP ("WGC"), which is an FSA authorised firm and a PLUS corporate adviser and broker, for a cash consideration of £250,000. 

WGC is owned by Edward Vandyk, his wife, Oliver Vaughan and Oliver Cooke Edward Vandyk and Oliver Vaughan are directors of Evolve Capital plc ("Evolve") and its 57% owned subsidiary Astaire Group plc ("Astaire"). WGC has entered into heads of agreement with Evolve ("WGC Heads") whereby Evolve will have a period of exclusivity to acquire WGC, conditional on and including the benefit of any contract WGC enters into with St Helen's Capital. No specific terms in relation to the proposed acquisition of WGC by Evolve are contained in the WGC Heads and such terms, if agreed, will be determined by the independent directors of Evolve in conjunction with Evolve's advisers and will constitute a related party transaction under the AIM Rules for Companies. It is also probable that if the proposed acquisition of WGC proceeds it will require the approval of Evolve's shareholders pursuant to section 190 of the Companies Act 2006 in which case, circular containing further information about the proposed acquisition of WGC and convening a General Meeting of Evolve to approve the proposed acquisition will be sent to Evolve's shareholders.

It is envisaged that Evolve may thus acquire an enlarged PLUS advisory business which, when the St Helen's Capital and WGC existing PLUS quoted clients are combined, will have over 25 PLUS quoted clients and be a significant participant in the PLUS quoted market. It is envisaged that the PLUS advisory business acquired would trade under the St Helen's name. At the time of its flotation on AIM in December 2007 Evolve stated its intention to focus on the PLUS quoted market and which it has continued to pursue since its reverse takeover of Astaire in December 2008

The St Helen's Capital heads of agreement provide that the Disposal is subject, inter alia, to completion by WGC of its due diligence exercise and the execution of a definitive sale and purchase agreement ("Sale Agreement"). The heads of agreement provide a period of 3 months' exclusivity to WGC.

The Disposal will result in a fundamental change to the business of St Helen's Capital and would therefore be subject to the approval of the Company's shareholders. Accordingly, as soon as reasonably practicable following the signing of the Sale Agreement, a circular containing further information about the Disposal and convening a General Meeting of the Company to approve the Disposal will be sent to shareholders. If the Disposal is approved at the General Meeting, St Helen's Capital intends to continue to be traded on AIM and will be treated as an investment company.

St Helen's Capital also announces that, with effect from 20 July 2009, Barry Hocken, head of the Company's PLUS Market Division, has resigned as a Director of the Company to pursue other business interests overseas. Barry has agreed to act as a Consultant to St Helen's Capital for a period of at least 6 months following his resignation. Mark Anwyl will take over as head of the Company's PLUS Markets Division. 

The Directors of St Helen's Capital would like to thank to Barry for his immense contribution to the development of the Company's PLUS Markets Division and to wish him well for the future. 

Enquiries:

St Helen's Capital Plc 020 7628 5582

Mark Warde-Norbury

 

Strand Partners Limited (Nominated Adviser to St Helen's Capital Plc) 020 7409 3490

James Harris

 

St Brides Media & Finance Ltd (Financial PR to St Helen's Capital Plc) 020 7236 1177

Susie Callear

 

Whim Gully Capital LLP / Evolve Capital PLC 020 7448 4400

Edward Vandyk

 

Fairfax I.S. PLC (Nominated Adviser to Evolve Capital PLC)

Adam Hart and Jeremy Porter 020 7598 5368

 

Maitland (Financial PR to Evolve Capital PLC)

Neil Bennett and George Hudson 020 7379 5151

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISDBGDRRBDGGCG
Date   Source Headline
6th Nov 20151:24 pmRNSNorthfield UK Solar Update
17th Sep 20154:14 pmRNSResult of AGM
26th Aug 20153:23 pmRNSPosting of Annual Report and Notice of AGM
26th Aug 20158:12 amRNSNorthfield UK Solar Update
24th Aug 20154:04 pmRNSHolding(s) in Company
21st Aug 201511:03 amRNSShare Price Movement
28th Jul 20151:41 pmRNSFinal Results
3rd Jun 20154:30 pmRNSHolding(s) in Company
5th May 20155:03 pmRNSDirector/PDMR Shareholding
2nd Apr 20159:45 amRNSHolding(s) in Company
31st Mar 20153:16 pmRNSHolding(s) in Company
20th Feb 201512:52 pmRNSDirector/PDMR Shareholding
3rd Feb 20152:52 pmRNSDirector/PDMR Shareholding
2nd Feb 20155:24 pmRNSDirector/PDMR Shareholding
9th Dec 20144:41 pmRNSHolding(s) in Company
24th Sep 20142:28 pmRNSResult of AGM
27th Aug 20148:25 amRNSPosting of Annual Results and Notice of AGM
11th Aug 201410:13 amRNSHolding(s) in Company
25th Jul 201410:13 amRNSFinal Results
11th Apr 20142:33 pmRNSHolding(s) in Company
11th Apr 20148:55 amRNSDirector/PDMR Shareholding
8th Apr 20145:20 pmRNSHolding(s) in Company
18th Mar 20143:12 pmRNSHolding(s) in Company
17th Feb 20142:26 pmRNSCompletes Solar Funding Round
18th Dec 20132:37 pmRNSDirector/PDMR Shareholding
17th Dec 20137:00 amRNSInterim Results
9th Dec 20135:06 pmRNSHolding(s) in Company
17th Oct 201311:26 amRNSHolding(s) in Company
10th Oct 20132:42 pmRNSDirector/PDMR Shareholding
18th Sep 20132:12 pmRNSResult of AGM
3rd Sep 20131:45 pmRNSDirector/PDMR Shareholding
8th Aug 201311:34 amRNSPosting of Results & Notice of AGM
1st Aug 20132:13 pmRNSDirector/PDMR Shareholding
25th Jul 20134:41 pmRNSHolding(s) in Company
25th Jul 20137:00 amRNSFinal Results
26th Jun 20137:00 amRNSBoard change
3rd Apr 201310:58 amRNSDirector/PDMR Shareholding
30th Jan 20135:47 pmRNSHolding(s) in Company
13th Dec 20127:00 amRNSHalf Yearly Report
25th Sep 20123:53 pmRNSResult of AGM
17th Sep 20124:26 pmRNSPosting of Annual Report & Notice of AGM
4th Sep 20125:49 pmRNSHolding(s) in Company
4th Sep 20125:48 pmRNSHolding(s) in Company
15th Aug 20124:00 pmRNSFinal Results
18th Apr 201212:06 pmRNSDirector/PDMR Shareholding
22nd Mar 20122:53 pmRNSHolding(s) in Company
21st Feb 20123:58 pmRNSHolding(s) in Company
21st Feb 20123:54 pmRNSDirector/PDMR Shareholding
21st Dec 20117:00 amRNSHalf Yearly Report
11th Nov 20113:58 pmRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.